---
schema_version: "secwatch.filing_event.v1"
accession: "0001171843-26-001362"
form_type: "8-K"
ticker: "PROF"
cik: "0001628808"
company_name: "Profound Medical Corp."
filed_at: "2026-03-05T23:59:59+00:00"
generated_at: "2026-05-15T19:41:09.734393+00:00"
event_type: "earnings"
sentiment: "neutral"
materiality_score: 0.75
calibrated_materiality_score: 0.75
confidence: "high"
source: SEC EDGAR
---

# Profound Medical Q4 revenue $6M (+43% YoY), net loss $8.2M; installed base 78 TULSA-PRO

## Summary
- Q4 revenue record $6.0M (+43% YoY); net loss $8.2M ($0.27/sh) vs $4.9M loss year ago.
- FY2025 revenue $16.1M (up from $10.7M); net loss $42.6M ($1.41/sh) vs $27.8M loss.
- TULSA-PRO installed base 78, pipeline 110; expects ~120 installs by end of 2026.
- Dec 2025 financing: $36M US offering + $6.45M Canadian private placement; cash $59.7M.
- Board change: Kris Shah resigns, Frank Baylis appointed; Baylis co-founded Baylis Medical (sold for $1.75B).

## SEC filing metadata
- accession: 0001171843-26-001362
- form_type: 8-K
- ticker: PROF
- cik: 0001628808
- company_name: Profound Medical Corp.
- filed_at: 2026-03-05T23:59:59+00:00
- event_type: earnings
- sentiment: neutral
- materiality_score: 0.75
- calibrated_materiality_score: 0.75
- confidence: high
- sec_items: 2.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1628808/000117184326001362/0001171843-26-001362-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1628808/000117184326001362/f8k_030526.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001171843-26-001362
- JSON: https://secwatch.observer/filing/0001171843-26-001362.json
- Plain text: https://secwatch.observer/filing/0001171843-26-001362.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.